<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34674005</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>269</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions.</ArticleTitle><Pagination><StartPage>2265</StartPage><EndPage>2274</EndPage><MedlinePgn>2265-2274</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-021-10848-4</ELocationID><Abstract><AbstractText>Acute and post-acute neurological symptoms, signs and diagnoses have been documented in an increasing number of patients infected by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which causes Coronavirus Disease 2019 (COVID-19). In this review, we aimed to summarize the current literature addressing neurological events following SARS-CoV-2 infection, discuss limitations in the existing literature and suggest future directions that would strengthen our understanding of the neurological sequelae of COVID-19. The presence of neurological manifestations (symptoms, signs or diagnoses) both at the onset or during SARS-CoV-2 infection is associated with a more severe disease, as demonstrated by a longer hospital stay, higher in-hospital death rate or the continued presence of sequelae at discharge. Although biological mechanisms have been postulated for these findings, evidence-based data are still lacking to clearly define the incidence, range of characteristics and outcomes of these manifestations, particularly in non-hospitalized patients. In addition, data from low- and middle-income countries are scarce, leading to uncertainties in the measure of neurological findings of COVID-19, with reference to geography, ethnicity, socio-cultural settings, and health care arrangements. As a consequence, at present a specific phenotype that would specify a post-COVID (or long-COVID) neurological syndrome has not yet been identified.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beghi</LastName><ForeName>Ettore</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2542-0469</Identifier><AffiliationInfo><Affiliation>Laboratory of Neurological Disorders, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy. ettore.beghi@marionegri.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giussani</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Neurological Disorders, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westenberg</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Centre for Global Health, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allegri</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cognitive Neurology, Instituto de Investigaciones Neurol&#xf3;gicas Fleni, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Azorin</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital Cl&#xed;nico Universitario Valladolid, Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guekht</LastName><ForeName>Alla</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Moscow Research and Clinical Center for Neuropsychiatry &amp; Russian National Research Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frontera</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kivipelto</LastName><ForeName>Miia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangialasche</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukaetova-Ladinska</LastName><ForeName>Elizabeta B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasad</LastName><ForeName>Kameshwar</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Deapartment of Neurology, and Chief Executive Office, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, 834009, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chowdhary</LastName><ForeName>Neerja</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Mental Health and Substance Use, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winkler</LastName><ForeName>Andrea Sylvia</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Centre for Global Health, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="Y">Nervous System Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Neurological diseases</Keyword><Keyword MajorTopicYN="N">Post-COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Dr. Beghi reports grants from the Italian Ministry of Health, grants from SOBI, personal fees from Arvelle Therapeutics, grants from American ALS Association, outside the submitted work. Dr. Allegri reports grants from Fleni Neurological Institute (Buenos Aires, Argentina), grants from CONICET (National Council of Scientific and Technological Research), Argentina, grants from Washington University, Subcontract NIH (USA), grants from Alzheimer Association (USA), outside the submitted work. Dr. Garcia-Azorin reports grants from International Headache Society, personal fees from the World Health Organization, personal fees from Lilly, personal fees from Teva, personal fees from Novartis, personal fees from Allergan, personal fees from Chiesi, grants from the Spanish Society of Neurology, grants from Fundacion Estudios de Ciencias de la Salud de Castilla y Le&#xf2;n, grants from Colegio de Medicos de Valladolid, outside the submitted work. Dr. Frontera reports grants from NIH/NINDS and NIH/NIA for COVID-related research. Dr. Winkler and Dr. Westenberg report grants from School of Medicine of the Technical University of Munich, outside the submitted work. Dr. Guekht report a grant from the Russian Scientific Foundation, outside of the submitted work.All the other authors have nothing to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>21</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34674005</ArticleId><ArticleId IdType="pmc">PMC8528941</ArticleId><ArticleId IdType="doi">10.1007/s00415-021-10848-4</ArticleId><ArticleId IdType="pii">10.1007/s00415-021-10848-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi: 10.1136/bmj.m1091.Erratum.In:BMJ2020;368:m1295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1091.Erratum.In:BMJ2020;368:m1295</ArticleId><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Collantes MEV, Espiritu AI, Sy MCC, et al. Neurological manifestations in COVID-19 infection: a systematic review and meta-analysis. Can J Neurol Sci. 2021;48:66&#x2013;76. doi: 10.1017/cjn.2020.146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2020.146</ArticleId><ArticleId IdType="pmc">PMC7492583</ArticleId><ArticleId IdType="pubmed">32665054</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767&#x2013;783. doi: 10.1016/S1474-4422(20)30221-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30221-0</ArticleId><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Carlo DT, Montemurro N, Petrella G, et al. Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literature. J Neurol. 2021;268:1561&#x2013;1569. doi: 10.1007/s00415-020-09978-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09978-y</ArticleId><ArticleId IdType="pmc">PMC7395578</ArticleId><ArticleId IdType="pubmed">32740766</ArticleId></ArticleIdList></Reference><Reference><Citation>Romoli M, Jelcic I, Bernard-Valnet R, et al. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details. Eur J Neurol. 2020;27:1712&#x2013;1726. doi: 10.1111/ene.14382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14382</ArticleId><ArticleId IdType="pmc">PMC7300895</ArticleId><ArticleId IdType="pubmed">32503088</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman C, Mayer K, Sarwal A. Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19. Neurology. 2020;95:77&#x2013;84. doi: 10.1212/WNL.0000000000009673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009673</ArticleId><ArticleId IdType="pubmed">32345728</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardi M, Padovani A, McArthur JC. Neurological manifestations associated with COVID-19: a review and a call for action. J Neurol. 2020;267(6):1573&#x2013;1576. doi: 10.1007/s00415-020-09896-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09896-z</ArticleId><ArticleId IdType="pmc">PMC7238392</ArticleId><ArticleId IdType="pubmed">32436101</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. 2020;16:636&#x2013;644. doi: 10.1038/s41582-020-0398-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0398-3</ArticleId><ArticleId IdType="pmc">PMC7444680</ArticleId><ArticleId IdType="pubmed">32839585</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci. 2021;12:573&#x2013;580. doi: 10.1021/acschemneuro.0c00793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00793</ArticleId><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Kang H, Li S, Zhao H. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;267:2179&#x2013;2184. doi: 10.1007/s00415-020-09929-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09929-7</ArticleId><ArticleId IdType="pmc">PMC7249973</ArticleId><ArticleId IdType="pubmed">32458193</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair AS, McAlpine LS, Gardin T, et al. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77(8):1018&#x2013;1027. doi: 10.1001/jamaneurol.2020.2065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2065</ArticleId><ArticleId IdType="pmc">PMC7484225</ArticleId><ArticleId IdType="pubmed">32469387</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppolu V, Shantha Raju T. Zika virus out-break: a review of neurological complications, diagnosis, and treatment options. J Neurovirol. 2018;24:255&#x2013;272. doi: 10.1007/s13365-018-0614-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-018-0614-8</ArticleId><ArticleId IdType="pubmed">29441490</ArticleId></ArticleIdList></Reference><Reference><Citation>Carod-Artal FJ. Neurological complications of Zika virus infection. Expert Rev Anti Infect Ther. 2018;16:399&#x2013;410. doi: 10.1080/14787210.2018.1466702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2018.1466702</ArticleId><ArticleId IdType="pubmed">29668332</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy D. Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir. J Antimicrob Chemother. 2010;65(Suppl 2):ii35&#x2013;40. doi: 10.1093/jac/dkq014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkq014</ArticleId><ArticleId IdType="pmc">PMC2835510</ArticleId><ArticleId IdType="pubmed">20215134</ArticleId></ArticleIdList></Reference><Reference><Citation>Chacon R, Mirza S, Rodriguez D, et al. Demographic and clinical characteristics of deaths associated with influenza A(H1N1) pdm09 in Central America and Dominican Republic 2009&#x2013;2010. BMC Public Health. 2015;15:734. doi: 10.1186/s12889-015-2064-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-015-2064-z</ArticleId><ArticleId IdType="pmc">PMC4521479</ArticleId><ArticleId IdType="pubmed">26227404</ArticleId></ArticleIdList></Reference><Reference><Citation>Coltart CE, Lindsey B, Ghinai I, Johnson AM, Heymann DL. The Ebola outbreak, 2013&#x2013;2016: old lessons for new epidemics. Philos Trans R Soc Lond B Biol Sci. 2017;372(1721):20160297. doi: 10.1098/rstb.2016.0297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2016.0297</ArticleId><ArticleId IdType="pmc">PMC5394636</ArticleId><ArticleId IdType="pubmed">28396469</ArticleId></ArticleIdList></Reference><Reference><Citation>Billioux BJ. Neurological complications and sequelae of Ebola virus disease. Curr Infect Dis Rep. 2017;19:19. doi: 10.1007/s11908-017-0573-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11908-017-0573-x</ArticleId><ArticleId IdType="pubmed">28391498</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong G, Qiu X, Bi Y, et al. More challenges from Ebola: infection of the central nervous system. J Infect Dis. 2016;214(Suppl 3):S294&#x2013;296. doi: 10.1093/infdis/jiw257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw257</ArticleId><ArticleId IdType="pmc">PMC5050477</ArticleId><ArticleId IdType="pubmed">27707893</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Thibaut H, Strating J, van Kuppeveld F. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol. 2018;16:368&#x2013;381. doi: 10.1038/s41579-018-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones E, Pillay TD, Liu F, et al. Outcomes following severe hand foot and mouth disease: a systematic review and meta-analysis. Eur J Paediatr Neurol. 2018;22:763&#x2013;773. doi: 10.1016/j.ejpn.2018.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpn.2018.04.007</ArticleId><ArticleId IdType="pmc">PMC6148319</ArticleId><ArticleId IdType="pubmed">29778429</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai L, Hsieh S, Chang Y. Neurological manifestations in severe acute respiratory syndrome. Acta Neurol Taiwan. 2005;14:113&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">16252612</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J, Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202:415&#x2013;424. doi: 10.1084/jem.20050828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20050828</ArticleId><ArticleId IdType="pmc">PMC2213088</ArticleId><ArticleId IdType="pubmed">16043521</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad M, Omrani AS, Baig K, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis. 2014;29:301&#x2013;306. doi: 10.1016/j.ijid.2014.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2014.09.003</ArticleId><ArticleId IdType="pmc">PMC7110769</ArticleId><ArticleId IdType="pubmed">25303830</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE, Heo JH, Kim HO, et al. Neurological complications during treatment of Middle East respiratory syndrome. J Clin Neurol. 2017;13:227&#x2013;233. doi: 10.3988/jcn.2017.13.3.227.</Citation><ArticleIdList><ArticleId IdType="doi">10.3988/jcn.2017.13.3.227</ArticleId><ArticleId IdType="pmc">PMC5532318</ArticleId><ArticleId IdType="pubmed">28748673</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Li H, Fan R, et al. Coronavirus infections in the central nervous system and respiratory tract show distinct features in hospitalized children. Intervirology. 2016;59:163&#x2013;169. doi: 10.1159/000453066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000453066</ArticleId><ArticleId IdType="pmc">PMC7179523</ArticleId><ArticleId IdType="pubmed">28103598</ArticleId></ArticleIdList></Reference><Reference><Citation>Dessau R, Lisby G, Frederiksen J. Coronaviruses in spinal fluid of patients with acute monosymptomatic optic neuritis. Acta Neurol Scand. 1999;100:88&#x2013;91. doi: 10.1111/j.1600-0404.1999.tb01043.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1999.tb01043.x</ArticleId><ArticleId IdType="pmc">PMC7159732</ArticleId><ArticleId IdType="pubmed">10442448</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmi A, Ziola B, Hovi T, Reunanen M. Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients. Neurology. 1982;32:292&#x2013;295. doi: 10.1212/wnl.32.3.292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.32.3.292</ArticleId><ArticleId IdType="pubmed">6278362</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazzini E, Fleming J, Fahn S. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson&#x2019;s disease. Mov Disord. 1992;7:153&#x2013;158. doi: 10.1002/mds.870070210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.870070210</ArticleId><ArticleId IdType="pmc">PMC7168426</ArticleId><ArticleId IdType="pubmed">1316552</ArticleId></ArticleIdList></Reference><Reference><Citation>Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976&#x2013;1977. Am J Epidemiol. 1979;110:105&#x2013;123. doi: 10.1093/oxfordjournals.aje.a112795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a112795</ArticleId><ArticleId IdType="pubmed">463869</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeotti F, Massari M, D&#x2019;Alessandro R, et al. Risk of Guillain-Barr&#xe9; syndrome after 2010&#x2013;2011 influenza vaccination. Eur J Epidemiol. 2013;28:433&#x2013;444. doi: 10.1007/s10654-013-9797-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-013-9797-8</ArticleId><ArticleId IdType="pmc">PMC3672511</ArticleId><ArticleId IdType="pubmed">23543123</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahjouei S, Naderi S, Li J, et al. Risk of stroke in hospitalized SARS-CoV-2 infected patients: a multinational study. EBioMedicine. 2020;59:102939. doi: 10.1016/j.ebiom.2020.102939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102939</ArticleId><ArticleId IdType="pmc">PMC7429203</ArticleId><ArticleId IdType="pubmed">32818804</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcez FB, Aliberti MJR, Poco PCE, et al. Delirium and adverse outcomes in hospitalized patients with COVID-19. J Am Geriatr Soc. 2020;68:2440&#x2013;2446. doi: 10.1111/jgs.16803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16803</ArticleId><ArticleId IdType="pmc">PMC7460960</ArticleId><ArticleId IdType="pubmed">32835425</ArticleId></ArticleIdList></Reference><Reference><Citation>Benussi A, Pilotto A, Premi E, et al. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy. Neurology. 2020;95:e910&#x2013;e920. doi: 10.1212/WNL.0000000000009848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009848</ArticleId><ArticleId IdType="pubmed">32444493</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V, Amiri M, Lebech AM, et al. Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up. J Neurol. 2021 doi: 10.1007/s00415-020-10380-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10380-x</ArticleId><ArticleId IdType="pmc">PMC7803470</ArticleId><ArticleId IdType="pubmed">33438076</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta EM, Batra A, Clark JR, et al. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. 2020;7:2221&#x2013;2230. doi: 10.1002/acn3.51210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51210</ArticleId><ArticleId IdType="pmc">PMC7664279</ArticleId><ArticleId IdType="pubmed">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Salahuddin H, Afreen E, Sheikh IS, et al. Neurological predictors of clinical outcomes in hospitalized patients with COVID-19. Front Neurol. 2020;11:585944. doi: 10.3389/fneur.2020.585944.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.585944</ArticleId><ArticleId IdType="pmc">PMC7662675</ArticleId><ArticleId IdType="pubmed">33193048</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Sabadia S, Lalchan R, et al. A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City. Neurology. 2021;96:e575&#x2013;e586. doi: 10.1212/WNL.0000000000010979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010979</ArticleId><ArticleId IdType="pmc">PMC7905791</ArticleId><ArticleId IdType="pubmed">33020166</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SW, Kim SM, Kim YK, et al. Clinical characteristics and outcomes of COVID-19 cohort patients in Daegu Metropolitan City outbreak in 2020. J Korean Med Sci. 2021;36:e12. doi: 10.3346/jkms.2021.36.e12.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2021.36.e12</ArticleId><ArticleId IdType="pmc">PMC7781854</ArticleId><ArticleId IdType="pubmed">33398946</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa GJB, Garces TS, Cestari VRF, Flor&#xea;ncio RS, Moreira TMM, Pereira MLD. Mortality and survival of COVID-19. Epidemiol Infect. 2020;148:e123. doi: 10.1017/S0950268820001405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268820001405</ArticleId><ArticleId IdType="pmc">PMC7330281</ArticleId><ArticleId IdType="pubmed">32580809</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkler AE, Parikh NS, Mir S, et al. Risk of ischemic stroke in patients with Coronavirus Disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol. 2020;77:1&#x2013;7. doi: 10.1001/jamaneurol.2020.2730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2730</ArticleId><ArticleId IdType="pmc">PMC7333175</ArticleId><ArticleId IdType="pubmed">32614385</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaghi S, Ishida K, Torres J, et al. SARS-CoV-2 and stroke in a New York healthcare system. Stroke. 2020;51:2002&#x2013;2011. doi: 10.1161/STROKEAHA.120.030335.Erratum.In:Stroke2020;51(8):e179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.030335.Erratum.In:Stroke2020;51(8):e179</ArticleId><ArticleId IdType="pmc">PMC7258764</ArticleId><ArticleId IdType="pubmed">32432996</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry RJ, Smith CJ, Roffe C, et al. Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study. J Neurol Neurosurg Psychiatry. 2021;92:242&#x2013;248. doi: 10.1136/jnnp-2020-324927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-324927</ArticleId><ArticleId IdType="pubmed">33154179</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz JM, Libman RB, Wang JJ, et al. Cerebrovascular complications of COVID-19. Stroke. 2020;51:e227&#x2013;e231. doi: 10.1161/STROKEAHA.120.031265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.031265</ArticleId><ArticleId IdType="pmc">PMC7467046</ArticleId><ArticleId IdType="pubmed">32757751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ntaios G, Michel P, Georgiopoulos G, et al. Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke: the Global COVID-19 Stroke Registry. Stroke. 2020;51:e254&#x2013;e258. doi: 10.1161/STROKEAHA.120.031208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.031208</ArticleId><ArticleId IdType="pmc">PMC7359900</ArticleId><ArticleId IdType="pubmed">32787707</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew T, John SK, Sarma G, et al. COVID-19-related strokes are associated with increased mortality and morbidity: a multicenter comparative study from Bengaluru, South India. Int J Stroke. 2021;16:429&#x2013;436. doi: 10.1177/1747493020968236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1747493020968236</ArticleId><ArticleId IdType="pmc">PMC7723737</ArticleId><ArticleId IdType="pubmed">33034546</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes A, Herrmann FR, Genton L, et al. Incidence, characteristics and clinical relevance of acute stroke in old patients hospitalized with COVID-19. BMC Geriatr. 2021;21:52. doi: 10.1186/s12877-021-02006-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02006-2</ArticleId><ArticleId IdType="pmc">PMC7807227</ArticleId><ArticleId IdType="pubmed">33446113</ArticleId></ArticleIdList></Reference><Reference><Citation>de Havenon A, Ney JP, Callaghan B, et al. Impact of COVID-19 on outcomes in ischemic stroke patients in the United States. J Stroke Cerebrovasc Dis. 2021;30:105535. doi: 10.1016/j.jstrokecerebrovasdis.2020.105535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.105535</ArticleId><ArticleId IdType="pmc">PMC7832426</ArticleId><ArticleId IdType="pubmed">33310595</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcloughlin BC, Miles A, Webb TE, et al. Functional and cognitive outcomes after COVID-19 delirium. Eur Geriatr Med. 2020;11:857&#x2013;862. doi: 10.1007/s41999-020-00353-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41999-020-00353-8</ArticleId><ArticleId IdType="pmc">PMC7358317</ArticleId><ArticleId IdType="pubmed">32666303</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy M, Helfand BKI, Gou RY, et al. Delirium in older patients with COVID-19 presenting to the emergency department. JAMA Netw Open. 2020;3:e2029540. doi: 10.1001/jamanetworkopen.2020.29540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.29540</ArticleId><ArticleId IdType="pmc">PMC7677760</ArticleId><ArticleId IdType="pubmed">33211114</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Wang X, Jia X, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020;26:767&#x2013;772. doi: 10.1016/j.cmi.2020.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.04.012</ArticleId><ArticleId IdType="pmc">PMC7159868</ArticleId><ArticleId IdType="pubmed">32304745</ArticleId></ArticleIdList></Reference><Reference><Citation>Oates CP, Turagam MK, Musikantow D, et al. Syncope and presyncope in patients with COVID-19. Pacing Clin Electrophysiol. 2020;43:1139&#x2013;1148. doi: 10.1111/pace.14047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.14047</ArticleId><ArticleId IdType="pmc">PMC7461520</ArticleId><ArticleId IdType="pubmed">32840325</ArticleId></ArticleIdList></Reference><Reference><Citation>Talavera B, Garc&#xed;a-Azor&#xed;n D, Mart&#xed;nez-P&#xed;as E, et al. Anosmia is associated with lower in-hospital mortality in COVID-19. J Neurol Sci. 2020;419:117163. doi: 10.1016/j.jns.2020.117163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117163</ArticleId><ArticleId IdType="pmc">PMC7527278</ArticleId><ArticleId IdType="pubmed">33035870</ArticleId></ArticleIdList></Reference><Reference><Citation>Piroth L, Cottenet J, Mariet AS, et al. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med. 2021;9:251&#x2013;259. doi: 10.1016/S2213-2600(20)30527-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30527-0</ArticleId><ArticleId IdType="pmc">PMC7832247</ArticleId><ArticleId IdType="pubmed">33341155</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V, Amiri M, Christensen HK, Benros ME, Kondziella D. Thirty-day mortality and morbidity in COVID-19 positive vs. COVID-19 negative individuals and vs. individuals tested for Influenza A/B: a population-based study. Front Med (Lausanne) 2020;7:598272. doi: 10.3389/fmed.2020.598272.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.598272</ArticleId><ArticleId IdType="pmc">PMC7734212</ArticleId><ArticleId IdType="pubmed">33330562</ArticleId></ArticleIdList></Reference><Reference><Citation>Keddie S, Pakpoor J, Mousele C, et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr&#xe9; syndrome. Brain. 2021;144:682&#x2013;693. doi: 10.1093/brain/awaa433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa433</ArticleId><ArticleId IdType="pmc">PMC7799186</ArticleId><ArticleId IdType="pubmed">33313649</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E, Michael BD, Solomon T, Westenberg E, Winkler AS, on behalf of the COVID-19 Neuro Research Coalition Approaches to understanding COVID-19 and its neurological associations. Ann Neurol. 2021;89:1059&#x2013;1067. doi: 10.1002/ana.26076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26076</ArticleId><ArticleId IdType="pmc">PMC8250622</ArticleId><ArticleId IdType="pubmed">33836104</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med (Lausanne) 2021;8:3516. doi: 10.3389/fmed.2021.653516.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.653516</ArticleId><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E, Helbok R, Crean M, Chou SH, McNett M, Moro E, Bassetti C, EAN Neuro-COVID Task Force The European Academy of Neurology COVID-19 registry (ENERGY): an international instrument for surveillance of neurological complications in patients with COVID-19. Eur J Neurol. 2020 doi: 10.1111/ene.14652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14652</ArticleId><ArticleId IdType="pmc">PMC7753513</ArticleId><ArticleId IdType="pubmed">33220127</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J, Mainali S, Fink EL, et al. Global consortium study of neurological dysfunction in COVID-19 (GCS-NeuroCOVID): study design and rationale. Neurocrit Care. 2020;33:25&#x2013;34. doi: 10.1007/s12028-020-00995-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-020-00995-3</ArticleId><ArticleId IdType="pmc">PMC7243953</ArticleId><ArticleId IdType="pubmed">32445105</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Azor&#xed;n D, Abenza Abildua MJ, Erro Aguirre ME, et al. Neurological presentations of COVID-19: findings from the Spanish Society of Neurology NeuroCOVID-19 registry. J Neurol Sci. 2021;423:117283. doi: 10.1016/j.jns.2020.117283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117283</ArticleId><ArticleId IdType="pmc">PMC7749644</ArticleId><ArticleId IdType="pubmed">33636661</ArticleId></ArticleIdList></Reference><Reference><Citation>Troxel AB, Frontera JA, Mendoza-Puccini C. The National Institutes of Health COVID-19 NeuroDatabank and NeuroBiobank: a national resource for learning, discovery, and progress. Front Neurol. 2021;11:1865. doi: 10.3389/fneur.2020.615061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.615061</ArticleId><ArticleId IdType="pmc">PMC7843568</ArticleId><ArticleId IdType="pubmed">33519693</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler AS, Knauss S, Schmutzhard E, et al. A call for a global COVID-19 neuro research coalition. Lancet Neurol. 2020;19:482&#x2013;484. doi: 10.1016/S1474-4422(20)30150-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30150-2</ArticleId><ArticleId IdType="pmc">PMC7250549</ArticleId><ArticleId IdType="pubmed">32470416</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta EM, Spallone A, Rodriguez-Barradas MC, El Sahly HM, Atmar RL, Kulkarni PA. Postacute COVID-19: an overview and approach to classification. Open Forum Infect Dis. 2020;7:ofaa509. doi: 10.1093/ofid/ofaa509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa509</ArticleId><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>